Mounjaro

Indian Pharma Market 2026: Branded Generics, GLP-1 Agonists, And Chronic Therapies Set To Drive Growth

Indian Pharma Market 2026: Branded Generics, GLP-1 Agonists, And Chronic Therapies Set To Drive Growth

The Indian Pharmaceutical Market ended 2025 with Rs 2,40,672 crore, 8.1% growth. 2026 expected to grow 7.8–8.1%, driven by pricing,…

January 8, 2026

Mounjaro Over Ozempic, Diabetes & Weight Loss Drug Becomes India’s No.1 Selling Medicine | What To Know

Eli Lilly’s diabetes and obesity drug Mounjaro has become India’s top-selling pharmaceutical product by value in October. Its rising sales…

November 7, 2025